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associated with less favorable cognitive function, but this as-
sociation was largely attributable to demographic and car-
diovascular risk factors. Episodic asymptomatic hypotension 
in middle age may not be an independent cause of cognitive 
decline. Further study, including emphasis on neuroimag-
ing, is needed.  Copyright © 2009 S. Karger AG, Basel 
 Introduction 
 Orthostatic hypotension (OH) involves a marked de-
crease in blood pressure (BP) after assuming the upright 
posture. Established guidelines define OH as a decrease 
in systolic BP  6 20 mm Hg and/or a decrease in diastolic 
BP  6 10 mm Hg  [1] . Most research is based on elderly, 
clinical populations where symptomatic OH is associated 
with falls and fractures. In high-risk populations, OH is 
inconsistently associated with cardiovascular outcomes 
 [2, 3] and modestly associated with mortality  [2–4] , and 
is associated with incident hypertension  [5] , stroke  [6] , 
coronary heart disease (CHD)  [7] and mortality  [8] in 
middle-aged healthy adults. Cognitive function is associ-
ated with diabetes  [9, 10] , hypertension  [9, 10] , CHD  [9, 
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 Abstract 
 Background: To examine the association between ortho-
static hypotension (OH) and cognitive function in middle-
aged adults.  Methods: Participants were 12,702 men and 
women from the Atherosclerosis Risk in Communities Study. 
OH was defined as decrease in systolic blood pressure (BP) 
by  6 20 mm Hg or diastolic BP by  6 10 mm Hg upon stand-
ing. At the 2nd and the 4th follow-up examinations, cogni-
tive function was assessed using the Delayed Word Recall 
Test, Digit Symbol Substitution Test (DSST) and Word Flu-
ency Test (WFT).  Results: After age adjustment, those with 
OH were more likely to be in the lowest quintile of the DSST 
(OR = 1.34, 95% CI = 1.12–1.62) and WFT (OR = 1.25, 95% CI = 
1.03–1.51) than were those without OH. After adjustment for 
sociodemographic and cardiovascular risk factors, associa-
tions were no longer significant. In age-adjusted models 
only, OH was associated with increased odds of being in the 
greatest quintile of decline in DSST score between visits 2 
and 4 (OR = 1.28, 95% CI = 1.04–1.58).  Conclusions: OH was 
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11] and stroke  [9, 11] . Generally these conditions must be 
present in midlife to be associated with later life cognitive 
dysfunction  [12] .
 Beyond vascular risk factors, reduced cerebral blood 
flow may lead to cognitive dysfunction  [13] . This may ex-
plain the U-shaped association between systolic BP and 
cognitive performance in older populations  [14, 15] . It re-
mains unclear whether younger, otherwise healthy indi-
viduals are similarly at risk for cognitive impairment or 
other cerebral injury from decreased cerebral blood flow.
 Because OH leads to recurrent BP drops, this could 
result in cerebral hypoperfusion and impact cognitive 
function, perhaps via cerebral small-vessel disease, which 
is also associated with OH  [16] . However, the literature is 
inconclusive and limited to small studies of elderly per-
sons  [17] or others with comorbidities (e.g. Parkinson’s 
disease)  [18] . In one study of mostly diabetics, those with 
asymptomatic OH had lower cognitive function than 
those without OH  [19] . However, a study of elderly Finns 
found no differences in cognitive performance over 2 
years of follow-up by OH status  [20] .
 We examined the association between OH and cogni-
tive function in a large, biracial middle-aged cohort. We 
further examined the contribution of CVD risk factors to 
this association and whether cognitive decline over 6 
years was greater among those with OH at baseline.
 Methods 
 Study Population 
 The Atherosclerosis Risk in Communities (ARIC) Study is a 
prospective study of middle-aged African-American and white 
men and women that investigates the natural history of athero-
sclerosis and CVD. At baseline (1987–1989), 15,792 participants 
were sampled from 4 US communities: Forsyth County, N.C.; 
Jackson, Miss.; suburbs of Minneapolis, Minn., and Washing-
ton County, Md. African-Americans were sampled exclusively 
in Jackson and oversampled in Forsyth to ensure race-specific 
estimates. The Minneapolis and Washington County subjects 
were predominantly white. Response rates and details about the 
study design are published  [21, 22] . After baseline, there were 3 
triennial examinations, the last occurring between 1996 and 
1999.
 Exclusion criteria are presented in  figure 1 a. Briefly, of base-
line participants, we excluded those with an ethnicity other than 
African-American or white and African-Americans in Minne-
apolis and Washington County (n = 89), those not between the 
ages of 45 and 64 years (n = 172) and those without seated BP data 
(n = 3) or with missing data precluding the computation of base-
line postural BP change (n = 2,376). We also excluded individuals 
not participating in the visit 2 examination or cognitive function 
testing (n = 145), those with prevalent/unknown baseline stroke 
status or those having an incident stroke between baseline and 
visit 2 (n = 257), and those taking antiparkinsonian medications 
(n = 48). Our final sample size was 12,702.
 In analyses of change in cognitive function between the 2nd 
and 4th examinations ( fig. 1 b), we further excluded 1,461 indi-
viduals not participating in the 4th examination (due to death or 
other reasons), 337 participants not participating in the cognitive 
function examinations, and 332 participants with a stroke/un-
known stroke status between the 2nd and 4th examinations, leav-
ing 10,572 participants.
 Measurement and Classification of BP Response to a Change 
in Posture 
 Orthostatic BP measurements were ascertained using a 
Dinamap 1846 SX oscillometric device, which has high within-
subject reliability and is comparable to Doppler ultrasound BP 
measurement  [23] . Following 20 min of supine rest, automated 
supine BP measurements were taken approximately every 30 s for 
2 min (2–5 measurements, 90% had  6 4 measurements). Partici-
pants were asked to stand, and as they stood, a BP measurement 
was taken. Measurements were repeated during the first 2 min 
after standing (2–5 measurements, 91% had  6 4 measurements). 
Because BP restabilization occurs during the first 30 s after stand-
ing  [24] , BP change was defined as the difference between the av-
erage of the standing and supine BP measurements, excluding the 
1st standing measurement.
 Assessment of Cognitive Function 
 In the 2nd (1990–1992) and 4th (1996–1999) ARIC examina-
tions, tests were administered to assess cognitive function. The 
Delayed Word Recall Test (DWRT) tests verbal learning and re-
cent memory. Participants learn a list of 10 nouns and after 5 min 
are asked to recall these words within 60 s. Scores range from 0 to 
10, with a 6-month test-retest reliability of 0.75 reported  [25] . The 
Digit Symbol Substitution Test (DSST), a subtest of the Wechsler 
Adult Intelligence Scale – Revised, assesses sustained attention 
and psychomotor speed and is a sensitive marker of brain damage. 
The testee pairs numbers with corresponding symbols using a 
code visible during time-limited testing. Scores range from 0 to 
93; short-term test-retest reliability ranges from 0.82 to 0.88  [26] . 
The Controlled Oral Word Association Test [Word Fluency Test 
(WFT)] of the Multilingual Aphasia Examination is a test of ex-
pressive language that detects frontal lobe damage  [27] and early 
mental decline in older persons  [28] . Over three 1-min trials, the 
testee lists as many words as possible that begin with 3 different 
letters. Its test-retest reliability is 0.82  [29] .
 Covariates 
 Standardized interviews were conducted to obtain partici-
pants’ self-report of sociodemographic and behavioral character-
istics. Education was classified as below high school diploma, 
high school diploma or at least some college. Smoking and alcohol 
status were categorized as former, current and never. Medications 
taken for hypertension and diabetes were based on the partici-
pants’ self-reported use during the previous 2 weeks.
 Participants were queried about their perception of their 
health compared to their peers (fair/poor or excellent/good). 
High-density lipoprotein and low-density lipoprotein cholesterol 
levels (mmol/l) were determined at a central laboratory using 
standardized methods  [22] . Two noninvasive measures of athero-
sclerosis, the ankle-brachial index [dichotomized to  ̂  0.90 (indi-
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cator of peripheral artery disease) and  1 0.90] and carotid artery 
intima-media thickness, determined by B-mode ultrasound  [30] , 
were included.
 Diabetes was defined as nonfasting plasma glucose  6 200 mg/
dl, fasting glucose  6 126 mg/dl, a self-reported history of diabetes 
and/or current diabetes treatment. Three seated BP measure-
ments were taken on the right arm with a random-zero sphygmo-
manometer after 5 min of rest, and the average of the 2nd and 3rd 
measurements was used. Hypertension was defined as systolic BP 
 6 140 mm Hg, diastolic BP  6 90 mm Hg and/or current use of 
antihypertensive medications. Resting heart rate was determined 
from a standard supine 12-lead electrocardiogram. Prevalence of 
cancer, CHD and stroke was based on self-report.
 We controlled for baseline use of antihypertensive medications. 
but not specific classes, as in our previous work there was little as-
sociation between OH and specific classes of antihypertensive 
agents  [8] . Analyses were conducted both including and excluding 
1,081 participants using selected classes of medications (benzodi-
azepines, benzisoxazoles, butyrophenones, tricyclic antidepres-
sants, and other antidepressants and antipsychotic medicines).
 Analyses 
 Logistic regression generated coefficients to calculate age-, 
race- and gender-adjusted proportions of risk factors and selected 
baseline conditions by OH status. Analysis of covariance was used 
to produce age-, race- and gender-adjusted means of risk factors 
by OH status and to estimate age-adjusted mean levels of perfor-
mance (6-year change) on the cognitive examinations.
 Performance on the cognitive examinations was also catego-
rized into quintiles, with those in the lowest quintile of perfor-
mance contrasted to those with more favorable performance. 
Higher raw scores indicated better performance on all tests. The 
lowest quintiles had the following cutoffs: on the DWRT,  ̂  5; on 
the DSST, 0–32; on the WFT, 0–22. For each examination, logistic 
regression models were run sequentially controlling for: (1) age, 
(2) age, gender, educational attainment and race/center, (3) same 
as No. 2 and systolic BP and antihypertensive medication use, and 
(4) same as No. 3 and current drinking, current smoking, diabe-
tes, carotid intima-media thickness, low ankle-brachial index, 
low-density lipoprotein cholesterol, resting heart rate, prevalent 
CHD, cancer and fair/poor self-reported health. Analyses were 
repeated excluding those reporting use of the selected medica-
tions previously described.
 Change in performance on the cognitive examinations be-
tween the 2nd and 4th examinations was calculated. Age-adjust-
ed mean change scores were calculated as were quintiles of change 
(visit 2 – visit 4 performance; the quintile of largest decrease was 
calculated). Logistic regression analyses estimated the associa-
tion between OH and change in cognitive function, using the 
strategy as described for cognitive function at visit 2.
 Results 
 Baseline OH and Initial Cognitive Performance 
 Individuals with OH at baseline were older, more fre-
quently African-American and of lower educational at-
tainment than those without OH ( table 1 ). Most vascular 
257 Prevalent or unknown stroke status at
baseline, or an incident stroke between
baseline and visit 2
12,702 participants
48 Taking antiparkinsonian medications
145 Did not participate in the visit 2
examination or cognitive function testing
2,376 Missing postural BP change data
3 Missing seated BP
measurements
172 Not between the ages of 45 and 64 years
89 Ethnicity other than African-American or
white or African-Americans in Minn. or Md.
15,792 participants at baseline
a
332 Incident or unknown stroke status
between visit 2 and visit 4
337 Did not participate in the cognitive
function testing





 Fig. 1.  a Exclusion criteria for analysis of the association of base-
line OH with cognitive function at the 2nd ARIC Study examina-
tion.  b Exclusion criteria for analysis of the association of baseline 
OH with change in cognitive function between the 2nd and 4th 
ARIC Study examinations. 
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risk factors and comorbidities were more common or se-
verer in those with OH compared with those without 
OH. Among hypertensive individuals, those with OH 
were modestly more likely to be using antihypertensive 
medications than those without OH.
 Table 2 provides a comparison of cognitive perfor-
mance at visit 2 by baseline OH status. Age-adjusted 
mean scores were significantly lower for those with base-
line OH for the DWRT and DSST.
 Baseline OH was associated with a 1.34-fold increased 
odds of poor performance on the DSST (age-adjusted
OR = 1.34, 95% CI = 1.12–1.62) and a 1.25-fold increased 
odds of poor performance on the WFT (age-adjusted
OR = 1.25, 95% CI = 1.03–1.51), with poor performance 
defined as the lowest quintile of each test ( table 3 ). With 
further adjustment, the associations were not significant, 
although point estimates indicated worse cognitive per-
formance in those with OH compared to those without 
OH. The greatest absolute reduction in the association 
was found for demographic characteristics rather than 
CVD risk factors. Results were similar after: (1) excluding 
those on medications associated with OH and/or known 
to affect cognitive function, (2) limiting analyses to par-
ticipants with no missing data on any covariates, and (3) 
analyzing the association between baseline OH and visit 
4 cognitive performance (data not shown).
 Baseline OH and Change in Cognitive Performance 
from Visit 2 to 4 
 Similar to baseline associations, persons with OH had 
less favorable change in the cognitive examinations than 
persons without OH. Mean age-adjusted decrease in the 
DSST score was 1.07 points for those with OH, whereas 
those without OH had a mean improvement of 1.07 points 
(p = 0.012). For the DWRT, the mean decrease for those 
with OH was 0.21 points, compared to a 0.06-point im-
provement for those without OH (p = 0.012). Compared 
to persons without OH, those with OH had a 21% (DWRT) 
and 28% (DSST) increased odds of being in the quintile 
of largest cognitive decline in age-adjusted models, but 
the association was statistically significant only for the 
DSST ( table 4 ). Adjusting for demographic factors pro-
duced the largest absolute reduction in strength of asso-
ciation. Adjusting for cardiovascular risk factors pro-
duced comparable reductions (data not shown).
OH no (n = 12,050) OH yes (n = 652)
Mean age, years 53.9 (53.8–54.0) 57.3 (56.8–57.7)
African-American, % 25.6 (24.8–26.4) 34.8 (31.1–38.6)
Male, % 45.1 (44.2–46.0) 44.2 (40.4–48.1)
Less than high school education, % 22.4 (21.6–23.3) 32.4 (28.7–36.3)
Mean body mass index 27.6 (27.6–27.7) 27.6 (27.2–28.0)
Mean carotid intima-media thickness, mm 0.75 (0.75–0.75) 0.82 (0.80–0.83)
Mean heart rate, beats/min 66.5 (66.3–66.7) 69.2 (68.4–69.9)
Low ankle-brachial index (≤0.90), % 2.9 (2.6–3.2) 7.6 (5.9–9.9)
Diabetes mellitus, % 11.5 (10.9–12.1) 18.6 (15.9–21.8)
Hypertension, % 33.3 (32.4–34.2) 53.2 (49.2–57.3)
History of coronary heart disease, % 4.8 (4.4–5.3) 7.5 (5.7–9.8)
Current smokers, % 25.6 (24.8–26.5) 34.6 (30.9–38.4)
Current alcohol use, % 56.9 (55.9–57.8) 48.7 (44.5–52.8)
Self-reported fair/poor health status 18.7 (17.9–19.5) 30.7 (27.0–34.7)
Means were adjusted for age, race and gender. Figures in parentheses are 95% CI. Body 
mass index is calculated by weight in kilograms per height in meters squared.
Table 1. Adjusted means and percentages 
of selected baseline risk factors and 
 conditions by OH status at the baseline 
ARIC examination (1987–1989)
Table 2. Age-adjusted mean scores on cognitive function exami-
nations at ARIC visit 2 (1990–1992) by baseline OH status
n OH no OH yes p value
Delayed word recall 12,657 6.6 6.4 0.003
Digit symbol 12,654 44.7 42.6 0.001
WFT 12,643 33.3 32.2 0.290
Digit symbol from the Wechsler Adult Intelligence Scale – Re-
vised.




 In the ARIC cohort, those with OH generally had 
worse baseline cognitive function than persons without 
OH, as well as a larger decrement in cognitive function 
over a 6-year interval, but this association was largely ex-
plained by demographic and other risk factors. The DSST, 
which assesses motor speed, was the most consistently 
affected. Psychomotor speed is often affected by subcor-
tical processes, including white matter ischemic disease 
 [31] . OH may result in recurrent episodes of hypoperfu-
sion of the white matter, thus leading to impaired cogni-
tive performance. Studies suggest an association between 
hypotension and white matter disease  [32, 33] , while au-
topsy studies suggest that Alzheimer’s disease may be as-
sociated with hypoperfusion of the deep white matter  [34, 
35] . OH is a form of hypoperfusion, perhaps damaging 
the brain via mechanisms similar to persistent hypoten-
sion  [36] . This may explain associations between OH and 
vascular dementia  [37] . OH has been associated with in-
cident stroke  [6] , which might further contribute to im-
paired cognitive function. Sensitivity analyses including 
stroke cases, however, produced similar results (data not 
shown).
 The minimal, nonsignificant association after adjust-
ment for sociodemographic factors suggests that asymp-
tomatic OH is not an important independent contributor 
to cognitive dysfunction in middle-aged otherwise 
healthy individuals. However, this does not preclude that 
OH has an effect on cognition in the setting of concurrent 
cerebrovascular disease.
 Prior studies have emphasized the importance of 
midlife risk factors in predicting later-life cognitive im-
pairment and dementia. In our study, associations were 
similar when measured within a short time frame: OH 
measurements were made at baseline, with initial cogni-
tive testing at the next triennial examination. This asso-
ciation may exist because OH indicates earlier (before 
midlife) risk factor exposures that contributed to both 
OH and impaired cognition in midlife. Also, OH may 
reflect atherosclerotic disease  [38] and, thus, be a marker 
of cerebrovascular burden. Although our findings do not 
Table 3. Association between baseline OH and poor cognitive function at the ARIC visit 2 examination (OR, with 95% CI in paren-
theses)
Covariates included Delayed word recall Digit symbol substitution Word fluency
(1) Age 1.18 (0.98–1.42) 1.34 (1.12–1.62) 1.25 (1.03–1.51)
(2) Model 1 + race/center, gender and education 1.11 (0.92–1.35) 1.15 (0.93–1.43) 1.12 (0.93–1.37)
(3) Model 2 + systolic BP and antihypertensive medications 1.11 (0.92–1.34) 1.16 (0.93–1.43) 1.10 (0.91–1.34)
(4) Model 3 + selected risk factors and conditions 1.07 (0.86–1.32) 1.17 (0.93–1.48) 1.09 (0.88–1.35)
Poor cognitive function defined as performance in the lowest quintile on the test. Risk factors in model 4: current drinking, cur-
rent smoking, diabetes mellitus, carotid intima-media thickness, low ankle-brachial index, low-density lipoprotein cholesterol, resting 
heart rate, prevalent CHD, cancer and fair/poor self-reported health.
Table 4. Associations between baseline OH and cognitive decline over an approximate 6-year period of the ARIC Study (OR, with 95% 
CI in parentheses)
Covariates included Delayed word recall Digit symbol substitution Word fluency 
(1) Age 1.21 (0.99–1.48) 1.28 (1.04–1.58) 1.11 (0.90–1.38)
(2) Model 1 + race/center, gender and education 1.16 (0.95–1.42) 1.14 (0.91–1.41) 1.03 (0.82–1.28)
(3) Model 2 + systolic BP and antihypertensive medications 1.15 (0.94–1.42) 1.13 (0.90–1.40) 1.03 (0.82–1.28)
(4) Model 3 + selected risk factors and conditions 1.08 (0.86–1.35) 1.05 (0.83–1.35) 1.03 (0.80–1.31)
Cognitive decline defined as the quintile of the largest decrease on test performance. Risk factors in model 4: current drinking, 
current smoking, diabetes, carotid intima-media thickness, low ankle-brachial index, low-density lipoprotein cholesterol, resting heart 
rate, prevalent CHD, cancer and fair/poor self-reported health.
 Rose /Couper /Eigenbrodt /Mosley /
Sharrett /Gottesman 
Neuroepidemiology 2010;34:1–76
suggest a clear association between OH and cognitive 
dysfunction, the absence of significant associations be-
tween OH and measures of cognitive function after ad-
justment for sociodemographic and cardiovascular risk 
factors could be due to type 2 error, given the relatively 
small sample of individuals with OH. Alternatively, it is 
possible that most healthy individuals have adequate ce-
rebral autoregulation to maintain cerebral blood flow 
when exposed to intermittent hypotension, and this is 
why on a population basis there are no apparent associa-
tions. Our lack of neuroimaging data, including informa-
tion about large-vessel stenoses of the neck and brain, 
may limit our ability to detect subgroups in whom there 
may be an association between OH and cognition. It is 
possible that individuals with significant extra- or intra-
cranial disease, or with significant leukoaraiosis, might 
be more vulnerable to cerebral effects of OH, either be-
cause of impaired cerebral autoregulation or particularly 
low cerebral blood flow in the presence of both OH and 
large-vessel stenosis.
 OH and cognition were not measured concurrently 
but ascertained from visits a few years apart. Thus, we 
could not explore relationships about transient altera-
tions in cognitive performance due to the presence of 
OH. However, given that OH was measured before the 
cognitive outcomes, this would be appropriate if OH were 
implicated in directly causing cognitive impairment.
 The primary associations in this study became non-
significant after adjustment for education, gender and 
race. This may partly be due to known associations with 
cardiovascular risk factors. Diabetes and hypertension 
are associated with a higher occurrence of both OH and 
cognitive dysfunction. While we controlled for both con-
ditions in our analyses, we did not have sufficient power 
to test for effect modification of OH-cognitive function 
associations by these conditions, or for the role of disease 
severity. However, in our earlier work, the strength of as-
sociations of OH with both CHD  [7] and mortality  [8] did 
not vary by diabetes or hypertension status. Also, as most 
hypertensive individuals were using antihypertensive 
medication, we could not exclude them from our analy-
ses. While we statistically controlled for this, we cannot 
rule out residual confounding. This is of less concern for 
other classes of medications, since results remained sim-
ilar after excluding persons using these medications.
 Conclusion 
 Our study suggests that much of the association be-
tween asymptomatic OH and poor cognition among a 
middle-aged healthy population may be due to other 
known factors. Further studies, particularly including 
neuroimaging, could provide evidence of the role of OH 
in the pathway from risk factors to cognitive decline.
 Acknowledgements and Funding 
 The ARIC Study is a collaborative study supported by the Na-
tional Heart, Blood and Lung Institute contracts N01-HC-55015, 
N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, 
N01-HC-55021 and N01-HC-55022. The authors thank the staff 




 1 Consensus statement on the definition of or-
thostatic hypotension, pure autonomic fail-
ure, and multiple system atrophy. J Neurol 
Sci 1996; 144: 218–219. 
 2 Luukinen H, Koski K, Laippala P, Airaksin-
en KE: Orthostatic hypotension and the risk 
of myocardial infarction in the home-dwell-
ing elderly. J Intern Med 2004; 255: 486–493. 
 3 Raiha I, Luutonen S, Piha J, Seppanen A, Toi-
kka T, Sourander L: Prevalence, predispos-
ing factors, and prognostic importance of 
postural hypotension. Arch Intern Med 
1995; 155: 930–935. 
 4 Masaki KH, Schatz IJ, Burchfiel CM, Sharp 
DS, Chiu D, Foley D, Curb JD: Orthostatic 
hypotension predicts mortality in elderly 
men: the Honolulu Heart Program. Circula-
tion 1998; 98: 2290–2295. 
 5 Rose KM, Holme I, Light KC, Sharrett AR, 
Tyroler HA, Heiss G: Association between 
the blood pressure response to a change in 
posture and the 6-year incidence of hyper-
tension: prospective findings from the ARIC 
Study. J Hum Hypertens 2002; 16: 771–777. 
 6 Eigenbrodt ML, Rose KM, Couper DJ, Ar-
nett DK, Smith R, Jones D: Orthostatic hy-
potension as a risk factor for stroke: the Ath-
erosclerosis Risk in Communities (ARIC) 
Study, 1987–1996. Stroke 2000;  31:  2307–
2313. 
 7 Rose KM, Tyroler HA, Nardo CJ, Arnett DK, 
Light KC, Rosamond W, Sharrett AR, Szklo 
M: Orthostatic hypotension and the inci-
dence of coronary heart disease: the Athero-
sclerosis Risk in Communities Study. Am J 
Hypertens 2000; 13: 571–578. 
 8 Rose KM, Eigenbrodt ML, Biga RL, Couper 
DJ, Light KC, Sharrett AR, Heiss G: Ortho-
static hypotension predicts mortality in 
middle-aged adults: the Atherosclerosis Risk 
in Communities (ARIC) Study. Circulation 
2006; 114: 630–636. 
 9 Knopman D, Boland LL, Mosley T, Howard 
G, Liao D, Szklo M, McGovern P, Folsom AR: 
Cardiovascular risk factors and cognitive 
decline in middle-aged adults. Neurology 
2001; 56: 42–48. 
 10 Kuo HK, Jones RN, Milberg WP, Tennstedt S, 
Talbot L, Morris JN, Lipsitz LA: Effect of 
blood pressure and diabetes mellitus on cog-
nitive and physical functions in older adults: 
a longitudinal analysis of the advanced cogni-
tive training for independent and vital elderly 
cohort. J Am Geriatr Soc 2005; 53: 1154–1161. 
 Orthostatic Hypotension and Cognitive 
Function 
Neuroepidemiology 2010;34:1–7 7
 11 Skoog I, Lithell H, Hansson L, Elmfeldt D, 
Hofman A, Olofsson B, Trenkwalder P, 
Zanchetti A: Effect of baseline cognitive 
function and antihypertensive treatment on 
cognitive and cardiovascular outcomes: 
study on cognition and prognosis in the el-
derly (SCOPE). Am J Hypertens 2005; 18: 
 1052–1059. 
 12 Freitag MH, Peila R, Masaki K, Petrovitch H, 
Ross GW, White LR, Launer LJ: Midlife pulse 
pressure and incidence of dementia: the Ho-
nolulu-Asia Aging Study. Stroke 2006; 37: 33–
37. 
 13 Mills S, Cain J, Purandare N, Jackson A: Bio-
markers of cerebrovascular disease in de-
mentia. Br J Radiol 2007; 80:S128–S145. 
 14 Glynn RJ, Beckett LA, Hebert LE, Morris 
MC, Scherr PA, Evans DA: Current and re-
mote blood pressure and cognitive decline. 
JAMA 1999; 281: 438–445. 
 15 Guo Z, Viitanen M, Winblad B, Fratiglioni L: 
Low blood pressure and incidence of demen-
tia in a very old sample: dependent on initial 
cognition. J Am Geriatr Soc 1999; 47: 723–
726. 
 16 Raiha I, Tarvonen S, Kurki T, Rajala T, 
Sourander L: Relationship between vascular 
factors and white matter low attenuation of 
the brain. Acta Neurol Scand 1993; 87: 286–
289. 
 17 Elmstahl S, Rosen I: Postural hypotension 
and EEG variables predict cognitive decline: 
results from a 5-year follow-up of healthy el-
derly women. Dement Geriatr Cogn Disord 
1997; 8: 180–187. 
 18 Allcock LM, Kenny RA, Mosimann UP, Tor-
doff S, Wesnes KA, Hildreth AJ, Burn DJ: 
Orthostatic hypotension in Parkinson’s dis-
ease: association with cognitive decline? Int 
J Geriatr Psychiatry 2006; 21: 778–783. 
 19 Perlmutter L, Greenberg J: Do you mind 
standing? Cognitive changes in orthostasis. 
Exp Aging Res 1996; 4: 325–341. 
 20 Viramo P, Luukinen H, Koski K, Laippala P, 
Sulkava R, Kivela SL: Orthostatic hypoten-
sion and cognitive decline in older people. J 
Am Geriatr Soc 1999; 47: 600–604. 
 21 Jackson R, Chambless LE, Yang K, Byrne T, 
Watson R, Folsom A, Shahar E, Kalsbeek W: 
Differences between respondents and non-
respondents in a multicenter community-
based study vary by gender ethnicity. The 
Atherosclerosis Risk in Communities 
(ARIC) Study investigators. J Clin Epidemiol 
1996; 49: 1441–1446. 
 22 The Atherosclerosis Risk in Communities 
(ARIC) Study: design and objectives. The 
ARIC investigators. Am J Epidemiol 1989; 
 129: 687–702. 
 23 Mundt KA, Chambless LE, Burnham CB, 
Heiss G: Measuring ankle systolic blood 
pressure: validation of the Dinamap 1846 
SX. Angiology 1992; 43: 555–566. 
 24 Smith JJ, Porth CM, Erickson M: Hemody-
namic response to the upright posture. J Clin 
Pharmacol 1994; 34: 375–386. 
 25 Knopman DS, Ryberg S: A verbal memory 
test with high predictive accuracy for de-
mentia of the Alzheimer type. Arch Neurol 
1989; 46: 141–145. 
 26 Wechsler D: Manual for the Wechsler Adult 
Intelligence Scale – Revised. New York, Psy-
chological Corporation, 1981. 
 27 Tranel D: Neuropsychological assessment. 
Psychiatr Clin North Am 1992; 15: 283–299. 
 28 Benton AL, Eslinger PJ, Damasio AR: Nor-
mative observations on neuropsychological 
test performances in old age. J Clin Neuro-
psychol 1981; 3: 33–42. 
 29 Franzen M: Multilingual Aphasia Examina-
tion. Kansas City, Test Corporation of Amer-
ica, 1986. 
 30 Riley WA: Non-invasive ultrasonic measure-
ment of carotid artery wall thickness in the 
ARIC cohort. Neuroimaging 1991; 1: 168–
172. 
 31 Mosley TH Jr, Knopman DS, Catellier DJ, 
Bryan N, Hutchinson RG, Grothues CA, Fol-
som AR, Cooper LS, Burke GL, Liao D, Sz-
klo M: Cerebral MRI findings and cognitive 
functioning: the Atherosclerosis Risk in 
Communities Study. Neurology 2005;  64: 
 2056–2062. 
 32 de Leeuw FE, de Groot JC, Oudkerk M, Wit-
teman JC, Hofman A, van Gijn J, Breteler 
MM: A follow-up study of blood pressure 
and cerebral white matter lesions. Ann Neu-
rol 1999; 46: 827–833. 
 33 van Dijk EJ, Breteler MM, Schmidt R, Berger 
K, Nilsson LG, Oudkerk M, Pajak A, Sans S, 
de Ridder M, Dufouil C, Fuhrer R, Giam-
paoli S, Launer LJ, Hofman A: The associa-
tion between blood pressure, hypertension, 
and cerebral white matter lesions: Cardio-
vascular Determinants of Dementia Study. 
Hypertension 2004; 44: 625–630. 
 34 Miklossy J: Cerebral hypoperfusion induces 
cortical watershed microinfarcts which may 
further aggravate cognitive decline in Al-
zheimer’s disease. Neurol Res 2003; 25: 605–
610. 
 35 Suter OC, Sunthorn T, Kraftsik R, Straubel J, 
Darekar P, Khalili K, Miklossy J: Cerebral 
hypoperfusion generates cortical watershed 
microinfarcts in Alzheimer disease. Stroke 
2002; 33: 1986–1992. 
 36 Cohen MB, Mather PJ: A review of the asso-
ciation between congestive heart failure and 
cognitive impairment. Am J Geriatr Cardiol 
2007; 16: 171–174. 
 37 Roman GC: Vascular dementia prevention: a 
risk factor analysis. Cerebrovasc Dis 2005; 
 20(suppl 2):91–100. 
 38 Mattace-Raso FU, van der Cammen TJ, 
Knetsch AM, van den Meiracker AH, 
Schalekamp MA, Hofman A, Witteman JC: 
Arterial stiffness as the candidate underly-
ing mechanism for postural blood pressure 
changes and orthostatic hypotension in old-
er adults: The Rotterdam Study. J Hypertens 
2006; 24: 339–344. 
 
